These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21845506)

  • 21. The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose.
    Newell HE; Buckton G; Butler DA; Thielmann F; Williams DR
    Pharm Res; 2001 May; 18(5):662-6. PubMed ID: 11465423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between mechanical properties and crystal structure in cocrystals and salt of paracetamol.
    Ahmed H; Shimpi MR; Velaga SP
    Drug Dev Ind Pharm; 2017 Jan; 43(1):89-97. PubMed ID: 27486671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of inverse gas chromatography (IGC) to determine the surface energy and surface area of powdered materials.
    Chow AH; Tong HH; Shekunov BY; York P
    Pharm Res; 2004 Sep; 21(9):1718-9; author reply 1719-20. PubMed ID: 15497701
    [No Abstract]   [Full Text] [Related]  

  • 24. Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug.
    Puri V; Shur J; Narang AS
    Mol Pharm; 2019 Oct; 16(10):4339-4351. PubMed ID: 31454254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the surface free energy of crystalline and amorphous lactose by atomic force microscopy adhesion measurement.
    Zhang J; Ebbens S; Chen X; Jin Z; Luk S; Madden C; Patel N; Roberts CJ
    Pharm Res; 2006 Feb; 23(2):401-7. PubMed ID: 16421667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of surface energetics of powders for drug delivery and the establishment of inverse gas chromatography.
    Buckton G; Gill H
    Adv Drug Deliv Rev; 2007 Dec; 59(14):1474-9. PubMed ID: 17928094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the surface energy distributions of different processed lactose.
    Thielmann F; Burnett DJ; Heng JY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1240-53. PubMed ID: 18058321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
    Raula J; Thielmann F; Naderi M; Lehto VP; Kauppinen EI
    Int J Pharm; 2010 Jan; 385(1-2):79-85. PubMed ID: 19879344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography.
    Davies M; Brindley A; Chen X; Marlow M; Doughty SW; Shrubb I; Roberts CJ
    Pharm Res; 2005 Jul; 22(7):1158-66. PubMed ID: 16028017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical properties and surface composition of infant formula powders.
    Saxena J; Adhikari B; Brkljaca R; Huppertz T; Chandrapala J; Zisu B
    Food Chem; 2019 Nov; 297():124967. PubMed ID: 31253317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the quality of powders for inhalation from surface energy and area.
    Cline D; Dalby R
    Pharm Res; 2002 Sep; 19(9):1274-7. PubMed ID: 12403062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of surface energy on powder compactibility.
    Fichtner F; Mahlin D; Welch K; Gaisford S; Alderborn G
    Pharm Res; 2008 Dec; 25(12):2750-9. PubMed ID: 18548337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Milling induced amorphisation and recrystallization of α-lactose monohydrate.
    Badal Tejedor M; Pazesh S; Nordgren N; Schuleit M; Rutland MW; Alderborn G; Millqvist-Fureby A
    Int J Pharm; 2018 Feb; 537(1-2):140-147. PubMed ID: 29262302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC.
    Kumon M; Suzuki M; Kusai A; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1508-14. PubMed ID: 17077547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface energy analysis as a tool to probe the surface energy characteristics of micronized materials--a comparison with inverse gas chromatography.
    Gamble JF; Leane M; Olusanmi D; Tobyn M; Supuk E; Khoo J; Naderi M
    Int J Pharm; 2012 Jan; 422(1-2):238-44. PubMed ID: 22100516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation.
    Wang C; Sun CC
    Mol Pharm; 2019 Apr; 16(4):1732-1741. PubMed ID: 30835128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.